Cracking the Capsid: Lenacapavir and the Next Chapter in HIV Treatment
The Warren Alpert Foundation and Harvard Medical School invite you to our annual scientific symposium, recognizing three scientists whose discoveries led to lenacapavir — a groundbreaking medication that offers new hope for preventing and treating HIV and accelerating the end of the epidemic.
Thursday, October 30
2–5:30 p.m.
Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
Boston, Massachusetts
Open to the public. Seating is on a first-come, first-served basis.
IN HONOR OF
- Tomas Cihlar, PhD
Senior vice president of research, virology, Gilead Sciences - John O. Link, AM ’87, PhD ’92
Former vice president of medicinal chemistry, Gilead Sciences
Scientific advisor, Actio Biosciences
Scientific advisory board member, Terremoto Biosciences - Wesley Sundquist, PhD
Samuels Distinguished Professor and chair of biochemistry, University of Utah
FEATURING
- Linda-Gail Bekker, MD, PhD
Professor and director of the Desmond Tutu HIV Centre, University of Cape Town
Chief executive officer of the Desmond Tutu Health Foundation - Pre-recorded conversation with Bill Gates
Chair, Gates Foundation
Founder, Breakthrough Energy and TerraPower, interviewed by Bruce Walker, MD, director, Ragon Institute of Mass General Brigham, MIT, and Harvard
For more information, please contact Caitlin Craig at 617-384-8467 or email
caitlin_craig@hms.harvard.edu.